Carbon monoxide releasing molecule-2 enhances coagulation in rat and rabbit plasma

Blood Coagulation and Fibrinolysis

Volumn 21, Issue 3, 2010, Pages 298-299

  Nielsen, Vance G ^a   Huneke, Richard B ^b   Khan, Ejaz S ^a  

^a Department of Anesthesiology ^*  (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE RELEASING MOLECULE 2; HEMOSTATIC AGENT; TRICARBONYLDICHLORORUTHENIUM; UNCLASSIFIED DRUG;

BLOOD CLOT LYSIS; BLOOD CLOTTING; CONTROLLED STUDY; DRUG EFFECT; HEMOSTASIS; LETTER; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT; THROMBOELASTOGRAPHY; THROMBOGENESIS;

ANIMALS; BLOOD COAGULATION; CARBON MONOXIDE; MALE; ORGANOMETALLIC COMPOUNDS; RABBITS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 77950275124     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e3283380c88     Document Type: Letter

References (4)

1. Nielsen VG, Kirklin JK, George JF. Carbon monoxide releasing molecule-2 increases the velocity of thrombus growth and strength in human plasma. Blood Coagul Fibrinolysis 2009; 20:377-380.
2. Nielsen VG, Kirklin JK, George JF. Carbon monoxide releasing molecule-2 decreases fibrinolysis in human plasma. Blood Coagul Fibrinolysis 2009; 20:448-455.
3. Nielsen VG, Kirklin JK, George JF. Carbon monoxide releasing molecule-2 increases the velocity of thrombus growth and strength in hemophilia A, hemophilia B and Factor VII deficient plasmas. Blood Coagul Fibrinolysis 2010; 21:41-45.
4. Nielsen VG, Kirklin JK, George JF. Carbon monoxide releasing molecule-2 decreases thick diameter fibrin fibre formation in normal and factor XIII deficient plasma. Blood Coagul Fibrinolysis 2010; 21:101-105.